Loading…

Health‐related Quality of Life of People with Epilepsy Compared with a General Reference Population: A Tunisian Study

Purpose: The goal of the study was to assess the health‐related quality of life (HRQOL) of persons with epilepsy (PWE) by using the short form survey 36 (SF‐36), to compare it with that of a control group and to detect factors influencing it. Methods: We collected clinical and demographic data and i...

Full description

Saved in:
Bibliographic Details
Published in:Epilepsia (Copenhagen) 2004-07, Vol.45 (7), p.838-843
Main Authors: Mrabet, Hela, Mrabet, Amel, Zouari, Bechir, Ghachem, Rim
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4253-8d9ffc37cad9e96142df68eba432414a8b1f059f99a48215f841b86f735f486b3
cites cdi_FETCH-LOGICAL-c4253-8d9ffc37cad9e96142df68eba432414a8b1f059f99a48215f841b86f735f486b3
container_end_page 843
container_issue 7
container_start_page 838
container_title Epilepsia (Copenhagen)
container_volume 45
creator Mrabet, Hela
Mrabet, Amel
Zouari, Bechir
Ghachem, Rim
description Purpose: The goal of the study was to assess the health‐related quality of life (HRQOL) of persons with epilepsy (PWE) by using the short form survey 36 (SF‐36), to compare it with that of a control group and to detect factors influencing it. Methods: We collected clinical and demographic data and information on health status by using the Arabic translation of the SF‐36 questionnaire from two groups: (a) 120 PWE consulting our outpatient clinic during a period of 4 months, and (b) 110 Tunisian citizens, representative of the Tunisian general population, as a control group. Results: The mean age of PWE group was 32.74 years, and 45.5% were men. Idiopathic generalized epilepsies were observed in 44.5% of cases, and symptomatic partial epilepsies, in 30%. The most commonly prescribed drug was sodium valproate (VPA). For the SF‐36, PWE had lower scores than the control group for only three subscales: general health perception, mental health, and social functioning. Seizure frequency, time since last seizure, and the antiepileptic drug (AED) side effects were the most important variables influencing the HRQOL among PWE. Seizure‐free adults have HRQOL levels comparable to those of the control group. Sociodemographic variables had no influence on the SF‐36 subscales. Conclusions: HRQOL is impaired in Tunisian PWE. The influencing factors identified in this study differ from the previously published data. Several possible reasons such as family support and cultural and religious beliefs are proposed to explain these cross‐cultural differences. A larger study should be conducted to verify such findings.
doi_str_mv 10.1111/j.0013-9580.2004.56903.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66669539</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66669539</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4253-8d9ffc37cad9e96142df68eba432414a8b1f059f99a48215f841b86f735f486b3</originalsourceid><addsrcrecordid>eNqNkMFu1DAQhi1ERZfCKyBf4JbUjp3E5oBUrZa20kosUM6Wk4xVr7xJsBNtc-MR-ox9EpzdVeHYucxo9P1j60MIU5LSWJfblBDKEpkLkmaE8DQvJGHpwyu0oHkmEkqL8jVaPEPn6G0IW0JIWZTsDTqPECMlJQu0vwHthvunP48enB6gwd9H7eww4c7gtTUw9w10vQO8t8M9XvXWQR8mvOx2vfYxcFhrfA0teO3wDzDgoa0Bb7p-jDdt137GV_hubG2wusU_h7GZ3qEzo12A96d-gX59Xd0tb5L1t-vb5dU6qXmWs0Q00pialbVuJMiC8qwxhYBKc5ZxyrWoqCG5NFJqLjKaG8FpJQpTstxwUVTsAn063u1993uEMKidDTU4p1voxqCKWDJnMoLiCNa-C8GDUb23O-0nRYmapautmn2q2aeapauDdPUQox9Ob4zVDpp_wZPlCHw8ATrU2hmv29qG_zhZ5kJkkfty5PbR8fTiD6jV5vYwsr9Mk56D</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66669539</pqid></control><display><type>article</type><title>Health‐related Quality of Life of People with Epilepsy Compared with a General Reference Population: A Tunisian Study</title><source>Wiley</source><creator>Mrabet, Hela ; Mrabet, Amel ; Zouari, Bechir ; Ghachem, Rim</creator><creatorcontrib>Mrabet, Hela ; Mrabet, Amel ; Zouari, Bechir ; Ghachem, Rim</creatorcontrib><description>Purpose: The goal of the study was to assess the health‐related quality of life (HRQOL) of persons with epilepsy (PWE) by using the short form survey 36 (SF‐36), to compare it with that of a control group and to detect factors influencing it. Methods: We collected clinical and demographic data and information on health status by using the Arabic translation of the SF‐36 questionnaire from two groups: (a) 120 PWE consulting our outpatient clinic during a period of 4 months, and (b) 110 Tunisian citizens, representative of the Tunisian general population, as a control group. Results: The mean age of PWE group was 32.74 years, and 45.5% were men. Idiopathic generalized epilepsies were observed in 44.5% of cases, and symptomatic partial epilepsies, in 30%. The most commonly prescribed drug was sodium valproate (VPA). For the SF‐36, PWE had lower scores than the control group for only three subscales: general health perception, mental health, and social functioning. Seizure frequency, time since last seizure, and the antiepileptic drug (AED) side effects were the most important variables influencing the HRQOL among PWE. Seizure‐free adults have HRQOL levels comparable to those of the control group. Sociodemographic variables had no influence on the SF‐36 subscales. Conclusions: HRQOL is impaired in Tunisian PWE. The influencing factors identified in this study differ from the previously published data. Several possible reasons such as family support and cultural and religious beliefs are proposed to explain these cross‐cultural differences. A larger study should be conducted to verify such findings.</description><identifier>ISSN: 0013-9580</identifier><identifier>EISSN: 1528-1167</identifier><identifier>DOI: 10.1111/j.0013-9580.2004.56903.x</identifier><identifier>PMID: 15230710</identifier><identifier>CODEN: EPILAK</identifier><language>eng</language><publisher>350 Main Street , Malden , MA 02148 , USA and 9600 Garsington Road , Oxford , OX4 2XG , England: Blackwell Science Inc</publisher><subject>Adolescent ; Adult ; Ambulatory Care ; Anticonvulsants - therapeutic use ; Biological and medical sciences ; Case-Control Studies ; Cross-Cultural Comparison ; Cross-Sectional Studies ; Cross‐cultural differences ; Epilepsy ; Epilepsy - diagnosis ; Epilepsy - drug therapy ; Epilepsy - ethnology ; Ethnic Groups - psychology ; Ethnic Groups - statistics &amp; numerical data ; Europe - ethnology ; Female ; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy ; Health Status ; Health Surveys ; Health‐related quality of life ; Humans ; Male ; Medical sciences ; Nervous system (semeiology, syndromes) ; Neurology ; Quality of Life ; SF‐36 ; Sickness Impact Profile ; Surveys and Questionnaires ; Tunisia - ethnology ; Valproic Acid - therapeutic use</subject><ispartof>Epilepsia (Copenhagen), 2004-07, Vol.45 (7), p.838-843</ispartof><rights>2004 INIST-CNRS</rights><rights>Copyright 2004 International League Against Epilepsy</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4253-8d9ffc37cad9e96142df68eba432414a8b1f059f99a48215f841b86f735f486b3</citedby><cites>FETCH-LOGICAL-c4253-8d9ffc37cad9e96142df68eba432414a8b1f059f99a48215f841b86f735f486b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27915,27916</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15975882$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15230710$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mrabet, Hela</creatorcontrib><creatorcontrib>Mrabet, Amel</creatorcontrib><creatorcontrib>Zouari, Bechir</creatorcontrib><creatorcontrib>Ghachem, Rim</creatorcontrib><title>Health‐related Quality of Life of People with Epilepsy Compared with a General Reference Population: A Tunisian Study</title><title>Epilepsia (Copenhagen)</title><addtitle>Epilepsia</addtitle><description>Purpose: The goal of the study was to assess the health‐related quality of life (HRQOL) of persons with epilepsy (PWE) by using the short form survey 36 (SF‐36), to compare it with that of a control group and to detect factors influencing it. Methods: We collected clinical and demographic data and information on health status by using the Arabic translation of the SF‐36 questionnaire from two groups: (a) 120 PWE consulting our outpatient clinic during a period of 4 months, and (b) 110 Tunisian citizens, representative of the Tunisian general population, as a control group. Results: The mean age of PWE group was 32.74 years, and 45.5% were men. Idiopathic generalized epilepsies were observed in 44.5% of cases, and symptomatic partial epilepsies, in 30%. The most commonly prescribed drug was sodium valproate (VPA). For the SF‐36, PWE had lower scores than the control group for only three subscales: general health perception, mental health, and social functioning. Seizure frequency, time since last seizure, and the antiepileptic drug (AED) side effects were the most important variables influencing the HRQOL among PWE. Seizure‐free adults have HRQOL levels comparable to those of the control group. Sociodemographic variables had no influence on the SF‐36 subscales. Conclusions: HRQOL is impaired in Tunisian PWE. The influencing factors identified in this study differ from the previously published data. Several possible reasons such as family support and cultural and religious beliefs are proposed to explain these cross‐cultural differences. A larger study should be conducted to verify such findings.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Ambulatory Care</subject><subject>Anticonvulsants - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Case-Control Studies</subject><subject>Cross-Cultural Comparison</subject><subject>Cross-Sectional Studies</subject><subject>Cross‐cultural differences</subject><subject>Epilepsy</subject><subject>Epilepsy - diagnosis</subject><subject>Epilepsy - drug therapy</subject><subject>Epilepsy - ethnology</subject><subject>Ethnic Groups - psychology</subject><subject>Ethnic Groups - statistics &amp; numerical data</subject><subject>Europe - ethnology</subject><subject>Female</subject><subject>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</subject><subject>Health Status</subject><subject>Health Surveys</subject><subject>Health‐related quality of life</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Quality of Life</subject><subject>SF‐36</subject><subject>Sickness Impact Profile</subject><subject>Surveys and Questionnaires</subject><subject>Tunisia - ethnology</subject><subject>Valproic Acid - therapeutic use</subject><issn>0013-9580</issn><issn>1528-1167</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNqNkMFu1DAQhi1ERZfCKyBf4JbUjp3E5oBUrZa20kosUM6Wk4xVr7xJsBNtc-MR-ox9EpzdVeHYucxo9P1j60MIU5LSWJfblBDKEpkLkmaE8DQvJGHpwyu0oHkmEkqL8jVaPEPn6G0IW0JIWZTsDTqPECMlJQu0vwHthvunP48enB6gwd9H7eww4c7gtTUw9w10vQO8t8M9XvXWQR8mvOx2vfYxcFhrfA0teO3wDzDgoa0Bb7p-jDdt137GV_hubG2wusU_h7GZ3qEzo12A96d-gX59Xd0tb5L1t-vb5dU6qXmWs0Q00pialbVuJMiC8qwxhYBKc5ZxyrWoqCG5NFJqLjKaG8FpJQpTstxwUVTsAn063u1993uEMKidDTU4p1voxqCKWDJnMoLiCNa-C8GDUb23O-0nRYmapautmn2q2aeapauDdPUQox9Ob4zVDpp_wZPlCHw8ATrU2hmv29qG_zhZ5kJkkfty5PbR8fTiD6jV5vYwsr9Mk56D</recordid><startdate>200407</startdate><enddate>200407</enddate><creator>Mrabet, Hela</creator><creator>Mrabet, Amel</creator><creator>Zouari, Bechir</creator><creator>Ghachem, Rim</creator><general>Blackwell Science Inc</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200407</creationdate><title>Health‐related Quality of Life of People with Epilepsy Compared with a General Reference Population: A Tunisian Study</title><author>Mrabet, Hela ; Mrabet, Amel ; Zouari, Bechir ; Ghachem, Rim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4253-8d9ffc37cad9e96142df68eba432414a8b1f059f99a48215f841b86f735f486b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Ambulatory Care</topic><topic>Anticonvulsants - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Case-Control Studies</topic><topic>Cross-Cultural Comparison</topic><topic>Cross-Sectional Studies</topic><topic>Cross‐cultural differences</topic><topic>Epilepsy</topic><topic>Epilepsy - diagnosis</topic><topic>Epilepsy - drug therapy</topic><topic>Epilepsy - ethnology</topic><topic>Ethnic Groups - psychology</topic><topic>Ethnic Groups - statistics &amp; numerical data</topic><topic>Europe - ethnology</topic><topic>Female</topic><topic>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</topic><topic>Health Status</topic><topic>Health Surveys</topic><topic>Health‐related quality of life</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Quality of Life</topic><topic>SF‐36</topic><topic>Sickness Impact Profile</topic><topic>Surveys and Questionnaires</topic><topic>Tunisia - ethnology</topic><topic>Valproic Acid - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mrabet, Hela</creatorcontrib><creatorcontrib>Mrabet, Amel</creatorcontrib><creatorcontrib>Zouari, Bechir</creatorcontrib><creatorcontrib>Ghachem, Rim</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Epilepsia (Copenhagen)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mrabet, Hela</au><au>Mrabet, Amel</au><au>Zouari, Bechir</au><au>Ghachem, Rim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Health‐related Quality of Life of People with Epilepsy Compared with a General Reference Population: A Tunisian Study</atitle><jtitle>Epilepsia (Copenhagen)</jtitle><addtitle>Epilepsia</addtitle><date>2004-07</date><risdate>2004</risdate><volume>45</volume><issue>7</issue><spage>838</spage><epage>843</epage><pages>838-843</pages><issn>0013-9580</issn><eissn>1528-1167</eissn><coden>EPILAK</coden><abstract>Purpose: The goal of the study was to assess the health‐related quality of life (HRQOL) of persons with epilepsy (PWE) by using the short form survey 36 (SF‐36), to compare it with that of a control group and to detect factors influencing it. Methods: We collected clinical and demographic data and information on health status by using the Arabic translation of the SF‐36 questionnaire from two groups: (a) 120 PWE consulting our outpatient clinic during a period of 4 months, and (b) 110 Tunisian citizens, representative of the Tunisian general population, as a control group. Results: The mean age of PWE group was 32.74 years, and 45.5% were men. Idiopathic generalized epilepsies were observed in 44.5% of cases, and symptomatic partial epilepsies, in 30%. The most commonly prescribed drug was sodium valproate (VPA). For the SF‐36, PWE had lower scores than the control group for only three subscales: general health perception, mental health, and social functioning. Seizure frequency, time since last seizure, and the antiepileptic drug (AED) side effects were the most important variables influencing the HRQOL among PWE. Seizure‐free adults have HRQOL levels comparable to those of the control group. Sociodemographic variables had no influence on the SF‐36 subscales. Conclusions: HRQOL is impaired in Tunisian PWE. The influencing factors identified in this study differ from the previously published data. Several possible reasons such as family support and cultural and religious beliefs are proposed to explain these cross‐cultural differences. A larger study should be conducted to verify such findings.</abstract><cop>350 Main Street , Malden , MA 02148 , USA and 9600 Garsington Road , Oxford , OX4 2XG , England</cop><pub>Blackwell Science Inc</pub><pmid>15230710</pmid><doi>10.1111/j.0013-9580.2004.56903.x</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0013-9580
ispartof Epilepsia (Copenhagen), 2004-07, Vol.45 (7), p.838-843
issn 0013-9580
1528-1167
language eng
recordid cdi_proquest_miscellaneous_66669539
source Wiley
subjects Adolescent
Adult
Ambulatory Care
Anticonvulsants - therapeutic use
Biological and medical sciences
Case-Control Studies
Cross-Cultural Comparison
Cross-Sectional Studies
Cross‐cultural differences
Epilepsy
Epilepsy - diagnosis
Epilepsy - drug therapy
Epilepsy - ethnology
Ethnic Groups - psychology
Ethnic Groups - statistics & numerical data
Europe - ethnology
Female
Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
Health Status
Health Surveys
Health‐related quality of life
Humans
Male
Medical sciences
Nervous system (semeiology, syndromes)
Neurology
Quality of Life
SF‐36
Sickness Impact Profile
Surveys and Questionnaires
Tunisia - ethnology
Valproic Acid - therapeutic use
title Health‐related Quality of Life of People with Epilepsy Compared with a General Reference Population: A Tunisian Study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T23%3A31%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Health%E2%80%90related%20Quality%20of%20Life%20of%20People%20with%20Epilepsy%20Compared%20with%20a%20General%20Reference%20Population:%20A%20Tunisian%20Study&rft.jtitle=Epilepsia%20(Copenhagen)&rft.au=Mrabet,%20Hela&rft.date=2004-07&rft.volume=45&rft.issue=7&rft.spage=838&rft.epage=843&rft.pages=838-843&rft.issn=0013-9580&rft.eissn=1528-1167&rft.coden=EPILAK&rft_id=info:doi/10.1111/j.0013-9580.2004.56903.x&rft_dat=%3Cproquest_cross%3E66669539%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4253-8d9ffc37cad9e96142df68eba432414a8b1f059f99a48215f841b86f735f486b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=66669539&rft_id=info:pmid/15230710&rfr_iscdi=true